Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients
Yawei Zhang(Sun Yat-sen University), Yulong He(The First Affiliated Hospital, Sun Yat-sen University)
Cited by 16
Related Papers
ITGAL as a Prognostic Biomarker Correlated With Immune Infiltrates in Gastric Cancer
|Frontiers in Cell and Developmental Biology|2022|42
Deregulation of miR-193b affects the growth of colon cancer cells via transforming growth factor-β and regulation of the SMAD3 pathway
|Oncology Letters|2017|34
GALNT1 Enhances Malignant Phenotype of Gastric Cancer via Modulating CD44 Glycosylation to Activate the Wnt/β-catenin Signaling Pathway
|International Journal of Biological Sciences|2022|34
Trim47 overexpression correlates with poor prognosis in gastric cancer
|Neoplasma|2020|25